Complete Report is available @ http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china.html China is the most populated country in the world. In 2012, its population was approximately 1.3 billion, approximately one fifth of the global population. Growth has however been effectively controlled and has slowed down due to the strict enforcement of family-planning and one-child policies. The decline in the size of the young working-age group and the growing elderly population are however matters of concern for policy planners. China’s pharmaceutical industry was estimated to be worth $287 billion in 2012. The market for western medicine was approximately $8.8 billion in 2007 and was estimated at $46.7 billion in 2012. The medical device market was worth approximately $20.1 billion in 2012 and is expected to reach approximately $53.5 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.1%.

1. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – China
Single User PDF: US$ 1995
Corporate User PDF: US$ 5985
Order this report by calling
+1 888 391 5441 or Send an email
to sales@marketoptimizer.org
with your contact details and
questions if any.
1

2. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – China
China is the most populated country in the world. In 2012, its population was
approximately 1.3 billion, approximately one fifth of the global population.
Growth has however been effectively controlled and has slowed down due to
the strict enforcement of family-planning and one-child policies. The decline in
the size of the young working-age group and the growing elderly population are
however matters of concern for policy planners. China’s pharmaceutical
industry was estimated to be worth $287 billion in 2012. The market for western
medicine was approximately $8.8 billion in 2007 and was estimated at $46.7
billion in 2012. The medical device market was worth approximately $20.1 billion
in 2012 and is expected to reach approximately $53.5 billion by 2020 at a
projected Compound Annual Growth Rate (CAGR) of 13.1%.
These positive trends can primarily be attributed to -
- Increasingly elderly population
- Widening healthcare insurance coverage
- Improved Intellectual Property Rights (IPR) environment
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
2

3. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – China
Researcher, the industry analysis specialist, has released its latest report,
“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China”.
The report is an essential source of information and analysis on the healthcare,
regulatory and reimbursement landscape in China. It identifies the key trends in
the healthcare market and provides insights into the demographic, regulatory,
reimbursement landscape and healthcare infrastructure. Most importantly, the
report provides valuable insights into the trends and segmentation of the
pharmaceutical and medical device markets. It is built using data and
information sourced from proprietary databases, secondary research, and in-
house analysis by Researcher’s team of industry experts.
Inquiry before buying this Report @
http://www.marketoptimizer.org/contacts/inquire-before-
buying?rname=2047 .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
3

4. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – China
Scope
The report provides information on the healthcare, regulatory and
reimbursement landscape in China, and includes -
- Overview of the pharmaceutical and medical devices markets, comprising
market size, segmentation, and key drivers and barriers
- Profiles and SWOT analysis of the major players in the pharmaceutical market,
of which the major Multinational Companies (MNCs) were GlaxoSmithKline
(GSK), Pfizer, and AstraZeneca; and the major domestic players were Harbin
Pharmaceutical Group and Tasly Pharmaceutical Group; and the medical device
market, of which the major players were Siemens Healthcare, GE Healthcare,
Fresenius Medical Care, GlaxoSmithKline, and Philips Healthcare
Complete Report is available @
http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-
reimbursement-landscape-china.html
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
4

5. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – China
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving
China’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory
policies, pharmaceutical and medical devices market segments, and companies
likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the
competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories
and segments that present the most opportunities for consolidation,
investments, and strategic partnerships
- Identify, understand and capitalize on the opportunities and challenges in
China’s healthcare market
Buy the copy of this Report @
http://www.marketoptimizer.org/contacts/purchase?rname=2047 .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
5

6. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – China
About Us
marketoptimizer.org is an online market research reports library of 250,000+ in-depth
studies of over 5000 micro markets. Our database includes reports by leading publishers
from across the globe. We provide 24/7 online and offline support service to our
customers. marketoptimizer.org also offers company data, country profiles, trends,
information and analysis on the sector of your interest.
Visit Us @
http://www.marketoptimizer.org
Follow Us:
Call Now + 1 888 391 5441 | Email sales @ sales@marketoptimizer.org
6